Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors

BACKGROUND: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampelj, Maja, Arko, Darja, Cas-Sikosek, Nina, Kavalar, Rajko, Ravnik, Maja, Jezersek-Novakovic, Barbara, Dobnik, Sarah, Dovnik, Nina Fokter, Takac, Iztok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722926/
https://www.ncbi.nlm.nih.gov/pubmed/26834522
http://dx.doi.org/10.2478/raon-2014-0049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722926/
https://www.ncbi.nlm.nih.gov/pubmed/26834522
http://dx.doi.org/10.2478/raon-2014-0049

Ejemplares similares